Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: A phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy

BACKGROUND: In recent years, preoperative volume reduction of locally advanced breast cancers, resulting in higher rates of breast-conserving surgery (BCS), has become increasingly important also in postmenopausal women. Clinical interest has come to center on the third-generation nonsteroidal aroma...

Descripción completa

Detalles Bibliográficos
Autores principales: Krainick-Strobel, Ute E, Lichtenegger, Werner, Wallwiener, Diethelm, Tulusan, Augustinus H, Jänicke, Fritz, Bastert, Gunther, Kiesel, Ludwig, Wackwitz, Birgit, Paepke, Stefan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270851/
https://www.ncbi.nlm.nih.gov/pubmed/18302747
http://dx.doi.org/10.1186/1471-2407-8-62

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270851/
https://www.ncbi.nlm.nih.gov/pubmed/18302747
http://dx.doi.org/10.1186/1471-2407-8-62

Ejemplares similares